|
|
View Department Homepage
Back To Top
View Department Homepage
TESTS:
Select a test to view Test Description & Clinical Indications | TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions |
| ACYLCARNITINE PROFILE, QUANTITATIVE |
ACYLP |
| AMINO ACIDS, QUANTITATIVE, CSF |
AACSF |
| AMINO ACIDS, QUANTITATIVE, PLASMA |
AAP |
| AMINO ACIDS, QUANTITATIVE, URINE |
AAUR |
| BIOTINIDASE |
BTDASE |
| BRANCHED CHAIN AMINO ACIDS |
BCAA |
| CARNITINE, FREE AND TOTAL, PLASMA/SERUM |
CARN |
| CARNITINE, FREE AND TOTAL, URINE |
UCARN |
| METHYLMALONIC ACID, SERUM |
MMAS |
| MUCOPOLYSACCHARIDES, TLC, URINE |
MPSTLC |
| MUCOPOLYSACCHARIDES, URINE, QUANTITATIVE |
MPSQNT |
| OLIGOSACCHARIDES, TLC, URINE |
OSTLC |
| ORGANIC ACIDS, QUALITATIVE, URINE |
UORG |
| OROTIC ACID, URINE |
UOROT |
| PHENYLALANINE AND TYROSINE |
PHATYR |
Back To Top
View Department Homepage
TESTS:
Select a test to view Test Description & Clinical Indications | TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions |
| -5/5Q- SEEN IN MDS, AML AND SECONDARY MDS AND AML |
CGFi5Q |
| -7/7Q- |
CGFi 7Q |
| 13Q DELETION IN MULTIPLE MYELOMA |
CGFi 13Q |
| 1P DELETION/19Q DELETION IN GLIOMAS [FRESH TUMOR TISSUE OR PARAFFIN-EMBEDDED TISSUE] |
FISH GLIOMA |
| 4P- SYNDROME (WOLF-HIRSCHHORN SYNDROME), 4P16.3 |
CGF MCDEL |
| 5P- SYNDROME (CRI DU CHAT SYNDROME), 5P15.2 |
CGF MCDEL |
| ALK GENE AMPLIFICATION |
FISH ALK |
| ANGELMAN SYNDROME (AS), 15Q11.2 (D15S10 DELETION) |
CGF ANGLM |
| ARRAY COMPARATIVE GENOMIC HYBRIDIZATION (ACGH) |
CGH GEN |
| BCR/ABL GENE FUSION IN CML AND ALL, T(9;22)(Q34;Q11.2) |
CGFi BCR |
| CBFB INVERSION/DELETION/TRANSLOCATION, INV(16)(P13Q22)/DEL(16Q)/T(16Q;?) IN AML-M4 |
CGFi inv(16) |
| CCND1/IGH GENE FUSION IN MANTLE CELL LYMPHOMA, T(11;14)(Q13;Q32) |
CGFi MCL |
| CENTROMERE PROBES (CROSS SEX TRANSPLANT; ANAUPLOIDY) |
CGFi ENUM |
| CHROMOSOME SPECIFIC SUBTELOMERIC PROBES |
CGF MAR |
| CLL PANEL (+12, 11Q AND 13Q DELETION, 17P DELETION) [PERIPHERAL BLOOD PREFERRED] |
CGFi CLL |
| CYTOGENETIC STUDY - AMNIOTIC FLUID |
CGAMNIO |
| CYTOGENETIC STUDY, BLOOD (CANCER DX.) |
CG BLD NEO |
| CYTOGENETIC STUDY, BLOOD, HIGH RESOLUTION |
CG HI RES |
| CYTOGENETIC STUDY, BLOOD, ROUTINE / PERCUTANEOUS UMBILICAL BLOOD SAMPLING (PUBS) |
CG BLOOD |
| CYTOGENETIC STUDY, BONE MARROW |
CG BONE MRW |
| CYTOGENETIC STUDY, CHORIONIC VILLI |
CGCVS |
| CYTOGENETIC STUDY, CHROMOSOME BREAKAGE FOR ATAXIA TELANGIECTASIA |
CG ATAXIA |
| CYTOGENETIC STUDY, CHROMOSOME BREAKAGE FOR FANCONI ANEMIA |
CG FANCONI |
| CYTOGENETIC STUDY, POC, TISSUE |
CG TISS POC |
| CYTOGENETIC STUDY, SKIN, TISSUE |
CG TISS SKIN |
| CYTOGENETIC STUDY, TUMOR |
CG TUMOR |
| DIGEORGE SEQUENCE/VELOCARDIOFACIAL SYNDROME (VCF), 22Q11.2 (TUPLE1 DELETION) AND DISTAL 22Q13.3 DELETION (ARSA) |
CGF VCF |
| ETO/AML1 GENE FUSION, T(8;21)(Q22;Q22), IN AML-M2 |
CGFi t(8;21) |
| EWS REARRANGEMENT, 22Q12 IN EWING'S SARCOMA, PNET, ETC.[FRESH TUMOR TISSUE OR PARAFFIN-EMBEDDED TISSUE] |
CGFi EWS or FISH EWS |
| FISH CHIC 2; DELETION (OR FIP1L1/PDGFRA FUSION) IN HES AND SMCD |
CGFi CHIC2 |
| FLUORESCENCE IN SITU HYBRIDIZATION (FISH) TESTING, PRENATAL PANEL |
CGF PRENAT |
| HER2 AMPLIFICATION IN BREAST CANCER [*PARAFFIN-EMBEDDED TISSUE] |
FISH HER2 |
| IGH/BCL2 GENE FUSION IN NHL, T(14;18)(Q32;Q21) |
CGFi FCL |
| IGH/FGFR3, FISH |
CGFi FGFR3 |
| MDM2 GENE AMPLIFICATION |
FISH MDM2 |
| MILLER-DIEKER SYNDROME (MDS), 17P13.3 (LIS1 DELETION) |
CGF MDK |
| MLL GENE REARRANGEMENT, 11Q23, IN AML AND ALL |
CGFi MLL |
| MYC GENE REARRANGEMENT, 8Q24, T(8;14)(Q24;Q32), T(2;8), T(8;22) |
CGFi cMYC or FISH BURKITT |
| OTHER UNIQUE SEQUENCE PROBES |
CGF MAR |
| PML/RARA GENE FUSION IN APL, T(15;17)(Q22;Q21) |
CGFi APL |
| PRADER-WILLI SYNDROME (PWS), 15Q11.2 (SNRPN DELETION) |
CGF PWS |
| PRENATAL FISH FOR TRISOMIES 13, 18 AND 21, X AND Y CHROMOSOMES (5-10 ML DIRECT AMNIOTIC FLUID) |
CGF PRENAT |
| SMITH-MAGENIS SYNDROME (SMS), 17P11.2 (FL1 DELETION) |
CGF SMS |
| SUBTELOMERIC FISH STUDIES FOR CRYPTIC REARRANGEMENTS |
CGF SUBTL |
| SYT REARRANGEMENT, 18Q11.2, IN SYNOVIAL SARCOMA, T(X;18) [*FRESH TUMOR TISSUE OR PARAFFIN-EMBEDDED TISSUE] |
FISH SYN SARC |
| TEL/AML1 GENE FUSION IN ALL, T(12;21)(P13;Q22) |
CGFi TEL |
| TRISOMY 8 |
CGFi ENUM |
| UROVYSION FLUORESCENCE IN SITU HYBRIDIZATION (FISH) SCREENING RECURRENT BLADDER CANCER |
CGFi UROV |
| UROVYSION SCREEN FOR RECURRENT BLADDER CANCER (ANEUPLOIDY OF CHROMOSOMES 3, 7 AND 17; DELETION OF 9P21) [VOIDED URINE] |
CGFi UROV |
| WHOLE CHROMOSOME PAINTS (TO IDENTIFY UNKNOWN REARRANGEMENTS/MARKERS) |
CGF WCPan |
| WILLIAMS SYNDROME (WS), 7Q11.23 (WSCR DELETION) |
CGF WMS |
| X-LINKED ICHTHYOSIS, XP22.3 (STEROID SULFATASE DELETION) |
CGF MCDEL |
Back To Top
View Department Homepage
TESTS:
Select a test to view Test Description & Clinical Indications | TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions |
| ADENOVIRUS QUANTITATIVE PCR, PLASMA ORDER |
ADVQT |
| BK VIRUS DNA PCR PLASMA, QUANTITATIVE |
BKVPC |
| BK VIRUS DNA PCR URINE, QUANTITATIVE |
BKVPCU |
| CHLAMYDIA/GC MOLECULAR DETECTION |
CLGC2 |
| CYTOMEGALOVIRUS QUANTITATIVE (CMV VIRAL LOAD) PCR |
CMVQT |
| CYTOMEGALOVIRUS(CMV) DNA, QUALITATIVE PCR, NON-PLASMA |
CMVQL |
| EPSTEIN BARR VIRUS (EBV) QUANTITATIVE PCR, PLASMA |
EBVQP |
| HEPATITIS B PCR QUANTITATIVE, SERUM |
HBPCR |
| HEPATITIS C QUANTITATIVE |
HCVPCR |
| HEPATITIS C VIRUS (HCV) GENOTYPE |
HCVGEN |
| HERPES SIMPLEX VIRUS (HSV) PCR, CSF |
HSVPCR |
| HHV-6 QUANTITATIVE PCR, PLASMA ORDER |
HHV6QT |
| HIV-1 ANTIVIRAL RESISTANCE TESTING - INTEGRASE |
AVIN |
| HIV-1 ANTIVIRAL RESISTANCE TESTING, PROTEASE AND REVERSE-TRANSCRIPTASE, PLASMA |
AVRT |
| HIV-1 RNA, QUANTITATIVE PCR, PLASMA |
HIVPCR |
| HPV 16/18 TYPING |
HPVPCR |
| HPV 6/11 TYPING |
HPV6PC |
| HUMAN METAPNEUMOVIRUS (hMPV) RNA, QUALITATIVE PCR |
MPVPCR |
| HUMAN PAPILLOMAVIRUS (HPV), DIGENE HC2 HIGH-RISK HPV DNA TEST |
HPVHR2 |
| RESPIRATORY SYNCYTIAL VIRUS (RSV) RNA, QUALITATIVE PCR |
RSVPCR |
Back To Top
View Department Homepage
TESTS:
Select a test to view Test Description & Clinical Indications | TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions |
| A/HYPOCHONDROPLASIA, AMNIOTIC FLUID |
FCHON |
| A/HYPOCHONDROPLASIA, WHOLE BLOOD |
CHON |
| ALPHA THALASSEMIA, AMNIOTIC FLUID |
FATHAL |
| ALPHA THALASSEMIA, BLOOD |
ATHAL |
| ALPHA THALASSEMIA, TISSUE |
TATHAL |
| B-CELL CLONALITY BY PCR ,BLOOD |
BCLON |
| B-CELL CLONALITY BY PCR, BONE MARROW |
BMBCLO |
| B-CELL CLONALITY BY PCR, FLUID |
FBCLO |
| B-CELL CLONALITY BY PCR, TISSUE |
TBCLO |
| BCR-ABL KINASE DOMAIN MUTATION ANALYSIS |
BCRKDM |
| BCR-ABL, BLOOD |
BCRABL |
| BCR-ABL, BONE MARROW |
BMBCR |
| BCR-ABL, QUANTITATIVE, BLOOD |
BCRQT |
| BCR-ABL, QUANTITATIVE, BONE MARROW |
BMBCRQ |
| BCR-ABL, QUANTITATIVE, FLUID |
FBCRQT |
| BCR-ABL, TISSUE |
TBCR |
| BETA THALASSEMIA SEQUENCING, AMNIOTIC FLUID |
FBTHSQ |
| BETA THALASSEMIA SEQUENCING, WHOLE BLOOD |
BTHSQ |
| BIOTINIDASE SEQUENCING ASSAY |
BIOSA |
| BRAF MUTATION ANALYSIS |
BRAF |
| CANCER SOMATIC MUTATION PROFILE (TISSUE) |
CSMP |
| CANCER SOMATIC MUTATION PROFILE (BLOOD) |
CSMPB |
| CANCER SOMATIC MUTATION PROFILE (BONE MARROW) |
CSMPBM |
| CEBPA; (BONE MARROW) |
BMCEBP |
| CEBPA; (PERIPHERAL BLOOD) |
CEBPA |
| CF POLY-T ANALYSIS |
CFPT |
| CFTR DELETION/DUPLICATION ANALYSIS BY MLPA |
CFMLPA |
| CFTR SCREEN BY SEQUENCING |
CFSS |
| CKIT MUTATION ANALYSIS |
CKITMU |
| CONNEXIN 26 SEQUENCING, AMNIOTIC FLUID |
FCX26S |
| CONNEXIN 26 SEQUENCING, BLOOD |
CX26S |
| CONNEXIN 30 |
CX30 |
| CYSTIC FIBROSIS DIAGNOSTIC SEQUENCING ASSAY |
CFDS |
| CYSTIC FIBROSIS MUTATION STUDY, NON BLOOD |
NCF32 |
| CYSTIC FIBROSIS MUTATION STUDY, WHOLE BLOOD |
CF32 |
| DUCHENNE AND BECKER MUSCULAR DYSTROPHY |
DBMD |
| EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION PANEL |
EGFRP |
| FACTOR II, PROTHROMBIN-20210A MUTATION, WHOLE BLOOD |
P20210 |
| FACTOR V LEIDEN, WHOLE BLOOD |
LEID |
| FAMILIAL GASTRIC CANCER |
CDH1 |
| FGFR1 CRANIOSYNOSTOSIS, BLOOD |
FGFR1 |
| FGFR2 CRANIOSYNOSTOSIS, BLOOD |
FGFR2 |
| FGFR3 MUENKE, BLOOD |
FGFR3 |
| FRAGILE X |
FRAGX |
| JANUS KINASE 2 V617F MUTATION, BLOOD |
JAK2 |
| JANUS KINASE 2 V617F MUTATION, NON-BLOOD |
NJAK2 |
| KIT D816V MUTATION BY AS-PCR, BLOOD |
D816V |
| KRAS MUTATION DETECTION |
KRAS |
| MATERNAL CELL CONTAMINATION - AMNIOTIC FLUID |
FMCC |
| MATERNAL CELL CONTAMINATION - TISSUE |
TMCC |
| METHYLENETETRAHYDROFOLATE REDUCTASE |
MTHFR |
| MGMT PROMOTER METHYLATION, BLOOD |
MGMTB |
| MICROSATELLITE INSTABILITY |
TMSI |
| NUCLEOPHOSMIN 1 MUTATION ANALYSIS, BLOOD |
NPM1 |
| NUCLEOPHOSMIN 1 MUTATION ANALYSIS, BONE MORROW |
BMNPM1 |
| PENDRED SYNDROME |
PDS |
| PRADER-WILLI SYNDROME |
PWS |
| PROMOTER METHYLATION DETECTION BY METHYLATION-SPECIFIC PCR |
MGMT |
| T(11;14) BY PCR, BLOOD |
T1114 |
| T(11;14) BY PCR, BONE MARROW |
BM1114 |
| T(11;14) BY PCR, FLUID |
FT1114 |
| T(11;14) BY PCR, TISSUE |
TT1114 |
| T(14;18) BY PCR: BONE MARROW |
BM1418 |
| T(14;18) BY PCR: FLUID |
FT1418 |
| T(14;18) BY PCR: TISSUE |
TT1418 |
| T(14;18) BY PCR: WHOLE BLOOD |
T1418 |
| T(15;17) PML-RAR, PCR: BLOOD |
T1517 |
| T(15;17) PML-RAR, PCR: BONE MARROW |
BM1517 |
| T(15;17) PML-RAR, PCR: FLUID |
FT1517 |
| T(15;17) PML-RAR, PCR: TISSUE |
TT1517 |
| T-CELL CLONALITY BY PCR REFLEX TO TCR-BETA (TCRB) REARRANGEMENTS - BLOOD |
TCLON |
| T-CELL CLONALITY BY PCR REFLEX TO TCR-BETA (TCRB) REARRANGEMENTS - BONE MARROW |
BMTCLO |
| T-CELL CLONALITY BY PCR REFLEX TO TCR-BETA (TCRB) REARRANGEMENTS - FLUID |
FTCLO |
| T-CELL CLONALITY BY PCR REFLEX TO TCR-BETA (TCRB) REARRANGEMENTS - TISSUE |
TTCLO |
| VH HYPERMUTATION: BLOOD |
VHHA |
| VH HYPERMUTATION: NON-BLOOD |
NVHHA |
Back To Top
View Department Homepage
TESTS:
Select a test to view Test Description & Clinical Indications | TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions |
| UNFRACTIONATED HEPARIN ACTIVITY BY ANTI-Xa ACTIVITY |
HEPAR |
| ACTIVATED PROTEIN C RESISTANCE |
APC |
| ADAMTS-13 PROFILE |
ADAMTS |
| ANTI-PHOSPHOLIPID ANTIBODY PANEL |
APHSA2 |
| ANTI-THROMBIN III PLASMA |
AT3 |
| BETA-2 GLYCOPROTEIN 1 |
B2GP1 |
| CARDIOLIPIN ANTIBODY, IGG AND IGM, SERUM |
ACA |
| D-DIMER (ELISA) |
DDIML |
| D-DIMER PLASMA, QUALITATIVE |
DDIM |
| DILUTE RUSSELL VIPER VENOM |
DRVVTP |
| EUGLOBULIN CLOT LYSIS |
ECL |
| FACTOR II ASSAY |
FACT2 |
| FACTOR IX ASSAY |
FACT9 |
| FACTOR V ASSAY |
FACT5 |
| FACTOR VII ASSAY |
FACT7 |
| FACTOR VIII ASSAY |
FACT8 |
| FACTOR VIII INHIBITOR, HUMAN |
F8INH |
| FACTOR X ASSAY |
FACT10 |
| FACTOR XI ASSAY |
FACT11 |
| FACTOR XII ASSAY |
FACT12 |
| FACTOR XIII SCREEN |
FACT13 |
| FIBRIN DEGRADATION PRODUCTS |
FDP |
| FIBRINOGEN ANTIGEN |
FIBANT |
| FREE PROTEIN S ACTIVITY, PLASMA |
PROTSF |
| HEPARIN PLATELET FACTOR 4 ANTIBODY |
HITAB |
| HEPARIN X A (FONDAPARINUX), PLASMA |
ARIX |
| HEPARIN-INDUCED PLATELET AGGREGATION |
HIPA |
| LMWH ACTIVITY BY ANTI-Xa ACTIVITY |
ANTIXA |
| LUPUS ANTICOAGULANT - PTTLA |
LUPUS |
| PLASMINOGEN ACTIVITY |
PLASMN |
| PLATELET AGGREGATION |
PLTAGG |
| PLATELET FUNCTION SCREEN |
PLTFUN |
| PLATELET INHIBITION BY THROMBOELASTOGRAPHY PLATELET MAPPING |
PLTMAP |
| PROTEIN C AND S, TOTAL COMBINED |
CSTOTL |
| PROTEIN C ANTIGEN, TOTAL |
TOTALC |
| PROTEIN C, ACTIVITY, PLASMA |
PROTC |
| PROTEIN S ANTIGEN, TOTAL |
TOTALS |
| PROTEIN S, ACTIVITY, PLASMA |
PROTS |
| PT INHIBITOR SCREEN |
PTINH |
| PTT INHIBITOR SCREEN |
PTTINH |
| REPTILASE TIME |
REPT |
| RISTOCETIN CO-FACTOR |
RIST |
| RISTOCETIN-INDUCED PLATELET AGGREGATION |
RIPA |
| THROMBIN TIME |
TT |
| VON WILLEBRAND DISEASE SCREEN |
VWSCN |
| VON WILLEBRAND FACTOR ANTIGEN PLASMA |
VWAG |
Back To Top
View Department Homepage
Back To Top View Here |
|
|
